Cui Zhicheng, President and Deputy Secretary of the Leading Party Members Group of Genertec Group, Visits Genertec Meheco Sanyang Pharma

On December 19, Cui Zhicheng, President and Deputy Secretary of the Leading Party Members Group of Genertec Group, visited Genertec Meheco Sanyang Pharma. During the visit, he toured the K201 facility and the Pharmaceutical Research Institute, extended greetings to frontline management and staff, and received work reports from Sanyang Pharma and Genertec Meheco's Innovation Drug and Medical Device Transformation Center regarding operational management and future development strategies. The delegation also held discussions on advancing the company's high-quality development.

During discussions, Cui Zhicheng commended Sanyang Pharma for its achievements in technological innovation and intelligent manufacturing. He outlined five directives for the company's next phase of development: First, capitalize on the operational launch of Hainan Free Trade Port by actively engaging international resources to explore new avenues for cross-border collaboration and sales expansion. Second, optimize production processes and streamline manufacturing lines to maximize capacity utilization, thereby enhancing operational efficiency and market competitiveness. Third, foster integrated innovation in pharmaceuticals and medical devices, accelerating the R&D and commercialization of key products to develop market-leading offerings. Fourth, align with the Group's synergy initiatives by implementing the "quality enhancement of existing products and breakthrough in new product development" strategy to support the Group's overarching strategies. Fifth, maintain firm confidence in high-quality growth and contribute to the Healthy China initiative through technological advancement.

The delegation also included Feng Chi, General Manager of the Group's Strategy Department; Sun Zhe, Deputy Director of the Group's Office; and Yang Guang, Chairman of Genertec Meheco.